Who is sponsoring NCT07075744?

NCT07075744 is sponsored by Asan Medical Center.

What drugs are being tested in NCT07075744?

Interventions in NCT07075744: Intraoperative Heart Rate Monitoring.

What condition does NCT07075744 study?

NCT07075744 studies HEART RATE.

Is NCT07075744 still recruiting?

NCT07075744 is currently completed. Last updated 20 July 2025.

Last reviewed 2025-07-20 · How we verify

NCT07075744

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intraoperative Heart Rate Thresholds and Postoperative Mortality

Completed Last updated 20 July 2025

What this trial tests

trial testing Intraoperative Heart Rate Monitoring in HEART RATE in 139,149 participants. Completed in 20 January 2025.

Timeline

30 August 2023

Primary endpoint
31 December 2024

20 January 2025

Quick facts

Lead sponsor	Asan Medical Center
Status	Completed
Study type	OBSERVATIONAL
Enrollment	139,149
Start date	30 August 2023
Primary completion	31 December 2024
Estimated completion	20 January 2025
Sites	1 location across South Korea

Drugs / interventions tested

Intraoperative Heart Rate Monitoring

Conditions studied

HEART RATE — all drugs for HEART RATE →

Sponsor

Asan Medical Center

Who can join

18 and older, any sex, with HEART RATE. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective observational study investigates the association between intraoperative heart rate and 30-day postoperative mortality among patients undergoing non-cardiac surgery. The findings suggest that heart rate abnormalities during surgery may significantly affect short-term postoperative outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Asan Medical Center trials

Trials by the same sponsor.

NCT07530393 — Blood Viscosity and Outcomes After Elective Craniotomy · not yet recruiting
NCT07010497 — A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Be · Phase 2 · recruiting
NCT07382505 — Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cerv · not yet recruiting
NCT07489092 — Feasibility of a Digital Rehabilitation Platform in Patients After ICU Discharge · NA · recruiting
NCT07431762 — Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprpsthetic Hear · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07075744 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asan Medical Center
Last refreshed: 20 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07075744.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing